Cases & Deals

Share

Neothetics and Evofem Biosciences merge

January 2018

Client(s) Invesco Advisers, Inc.

Jones Day advised Invesco Asset Management Limited in connection with the merger of Evofem Biosciences, Inc. with a wholly owned subsidiary of Neothetics, Inc. and the purchase by certain of Invesco's discretionary managed funds of common stock of the combined company.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.